Vaccinia virus-related nucleic acids and microRNA
View Patent ↗The present invention relates to a group of viral RNA regulatory genes, here identified as “viral genomic address messenger genes” or “VGAM genes”, and as “genomic record” or “GR” genes. VGAM genes selectively inhibit translation of known host target genes, and are believed to represent a pervasive viral attack mechanism. GR genes encode an operon-like cluster of VGAM genes. VGAM and viral GR genes may therefore be useful in diagnosing, preventing and treating viral disease. Several nucleic acid molecules are provided respectively encoding several VGAM genes, as are vectors and probes, both comprising the nucleic acid molecules, and methods and systems for detecting VGAM genes, and for counteracting their activity.
1. An isolated nucleic acid wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NOS: 128, 131, or 133;
(b) an RNA encoded by the nucleic acid of (a); or
(c) the complement of (a) or (b), wherein the complement is identical in length to (a) or (b).
2. An isolated nucleic acid, wherein the sequence of the nucleic acid consists of:
(a) SEQ ID NO:477, SEQ ID NO:480, or SEQ ID NO:482;
(b) an RNA encoded by the nucleic acid of (a); or
(c) the complement of (a) or (b), wherein the complement is identical in length to (a) or (b).
3. A vector comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 1 .
4. A vector comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 2 .
5. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 1 .
6. A probe comprising a heterologous sequence, wherein the heterologous sequence consists of the sequence of the nucleic acid of claim 2 .